NQVAX
Price
$58.20
Change
-$0.06 (-0.10%)
Updated
Jul 18 closing price
Net Assets
544.98M
VMVIX
Price
$65.84
Change
+$0.17 (+0.26%)
Updated
Jul 18 closing price
Net Assets
30.57B
Interact to see
Advertisement

NQVAX vs VMVIX

Header iconNQVAX vs VMVIX Comparison
Open Charts NQVAX vs VMVIXBanner chart's image
Nuveen Multi Cap Value A
Price$58.20
Change-$0.06 (-0.10%)
VolumeN/A
Net Assets544.98M
Vanguard Mid-Cap Value Index Investor
Price$65.84
Change+$0.17 (+0.26%)
VolumeN/A
Net Assets30.57B
NQVAX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NQVAX vs. VMVIX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NQVAX is a StrongBuy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.6B vs. NQVAX (545M). VMVIX pays higher dividends than NQVAX: VMVIX (2.14) vs NQVAX (1.24). NQVAX was incepted earlier than VMVIX: NQVAX (23 years) vs VMVIX (19 years). NQVAX (1.17) is less costly to investors than VMVIX (0.19). NQVAX is a more actively managed with annual turnover of: 24.00 vs. VMVIX (19.00). NQVAX has a lower initial minimum investment than VMVIX: NQVAX (2500) vs VMVIX (3000). NQVAX annual gain was more profitable for investors over the last year : 10.47 vs. VMVIX (5.78). NQVAX return over 5 years is better than : 126.35 vs. VMVIX (68.95).
NQVAXVMVIXNQVAX / VMVIX
Total Expense Ratio1.160.19611%
Annual Report Gross Expense Ratio1.170.19616%
Fund Existence23 years19 years-
Gain YTD6.9973.181220%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets545M30.6B2%
Annual Yield % from dividends1.242.1458%
Returns for 1 year10.475.78181%
Returns for 3 years60.7828.93210%
Returns for 5 years126.3568.95183%
Returns for 10 years147.7087.17169%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DDS461.6720.56
+4.66%
Dillards
JANX27.750.75
+2.78%
Janux Therapeutics
SKYH10.360.23
+2.27%
Sky Harbour Group Corporation
CLST12.280.01
+0.08%
Catalyst Bancorp
TDACU10.43N/A
N/A
Translational Development Acquisition Corp